These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
582 related articles for article (PubMed ID: 19838194)
21. High occurrence of CRLF2 abnormalities in Mexican children with B-cell acute lymphoblastic leukemia. Juárez-Velázquez MDR; Moreno-Lorenzana DL; Martínez Anaya DA; Hernández Monterde EA; Aguilar-Hernández MM; Reyes-León A; Chávez-González MA; López Santiago N; Zapata Tarrés M; Juárez Villegas L; Rivera Sánchez N; Soto Lerma O; Vega-Vega L; Rivera Luna R; Pérez-Vera P Cytokine; 2022 Jul; 155():155896. PubMed ID: 35537330 [TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of CRLF2 overexpression and JAK2 mutation in Egyptian pediatric patients with B-precursor acute lymphoblastic leukemia. Hassan NM; Abdellateif MS; Radwan EM; Hameed SA; Desouky EDE; Kamel MM; Gameel AM Clin Lymphoma Myeloma Leuk; 2022 Jun; 22(6):e376-e385. PubMed ID: 34987014 [TBL] [Abstract][Full Text] [Related]
23. Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group. Reshmi SC; Harvey RC; Roberts KG; Stonerock E; Smith A; Jenkins H; Chen IM; Valentine M; Liu Y; Li Y; Shao Y; Easton J; Payne-Turner D; Gu Z; Tran TH; Nguyen JV; Devidas M; Dai Y; Heerema NA; Carroll AJ; Raetz EA; Borowitz MJ; Wood BL; Angiolillo AL; Burke MJ; Salzer WL; Zweidler-McKay PA; Rabin KR; Carroll WL; Zhang J; Loh ML; Mullighan CG; Willman CL; Gastier-Foster JM; Hunger SP Blood; 2017 Jun; 129(25):3352-3361. PubMed ID: 28408464 [TBL] [Abstract][Full Text] [Related]
24. Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations. Buitenkamp TD; Pieters R; Gallimore NE; van der Veer A; Meijerink JP; Beverloo HB; Zimmermann M; de Haas V; Richards SM; Vora AJ; Mitchell CD; Russell LJ; Schwab C; Harrison CJ; Moorman AV; van den Heuvel-Eibrink MM; den Boer ML; Zwaan CM Leukemia; 2012 Oct; 26(10):2204-11. PubMed ID: 22441210 [TBL] [Abstract][Full Text] [Related]
25. Effects of different aberrations in the CRLF2 gene on the biological characteristics and drug sensitivities of Nalm6 cells. Gu M; Jia Y; Xu M; Feng J; Tian Z; Ma X; Wang M; Wang J; Xu Y; Rao Q; Hao L; Mi Y; Yang W Int J Lab Hematol; 2021 Jun; 43(3):441-449. PubMed ID: 33615710 [TBL] [Abstract][Full Text] [Related]
26. CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities. Chiaretti S; Brugnoletti F; Messina M; Paoloni F; Fedullo AL; Piciocchi A; Elia L; Vitale A; Mauro E; Ferrara F; De Fabritiis P; Luppi M; Ronco F; De Propris MS; Raponi S; Kronnie GT; Vignetti M; Guarini A; Foà R Leuk Res; 2016 Feb; 41():36-42. PubMed ID: 26754556 [TBL] [Abstract][Full Text] [Related]
27. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome. Bercovich D; Ganmore I; Scott LM; Wainreb G; Birger Y; Elimelech A; Shochat C; Cazzaniga G; Biondi A; Basso G; Cario G; Schrappe M; Stanulla M; Strehl S; Haas OA; Mann G; Binder V; Borkhardt A; Kempski H; Trka J; Bielorei B; Avigad S; Stark B; Smith O; Dastugue N; Bourquin JP; Tal NB; Green AR; Izraeli S Lancet; 2008 Oct; 372(9648):1484-92. PubMed ID: 18805579 [TBL] [Abstract][Full Text] [Related]
28. Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia. Russell LJ; Jones L; Enshaei A; Tonin S; Ryan SL; Eswaran J; Nakjang S; Papaemmanuil E; Tubio JM; Fielding AK; Vora A; Campbell PJ; Moorman AV; Harrison CJ Genes Chromosomes Cancer; 2017 May; 56(5):363-372. PubMed ID: 28033648 [TBL] [Abstract][Full Text] [Related]
29. Constitutive STAT5 activation in precursor B-cell acute lymphoblastic leukemia with P2RY8::CRLF2 fusion. Nieder R; Li W Blood; 2024 Oct; 144(15):1646. PubMed ID: 39388165 [No Abstract] [Full Text] [Related]
30. High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement. Ge Z; Gu Y; Zhao G; Li J; Chen B; Han Q; Guo X; Liu J; Li H; Yu MD; Olson J; Steffens S; Payne KJ; Song C; Dovat S Oncotarget; 2016 Aug; 7(31):49722-49732. PubMed ID: 27391346 [TBL] [Abstract][Full Text] [Related]
31. Frequent cases of RAS-mutated Down syndrome acute lymphoblastic leukaemia lack JAK2 mutations. Nikolaev SI; Garieri M; Santoni F; Falconnet E; Ribaux P; Guipponi M; Murray A; Groet J; Giarin E; Basso G; Nizetic D; Antonarakis SE Nat Commun; 2014 Aug; 5():4654. PubMed ID: 25105841 [TBL] [Abstract][Full Text] [Related]
32. Characterization of Philadelphia-like Pre-B Acute Lymphoblastic Leukemia: Experiences in Mexican Pediatric Patients. Martínez-Anaya D; Moreno-Lorenzana D; Reyes-León A; Juárez-Figueroa U; Dean M; Aguilar-Hernández MM; Rivera-Sánchez N; García-Islas J; Vieyra-Fuentes V; Zapata-Tarrés M; Juárez-Villegas L; Paredes-Aguilera R; Vega-Vega L; Rivera-Luna R; Juárez-Velázquez MDR; Pérez-Vera P Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076986 [TBL] [Abstract][Full Text] [Related]
33. Bilateral parotid gland swelling preceding the diagnosis of acute lymphoblastic leukemia with P2RY8-CRLF2 gene rearrangement. Juan YT; Wang YL; Jaing TH Pediatr Neonatol; 2023 May; 64(3):366-367. PubMed ID: 36967289 [No Abstract] [Full Text] [Related]
34. The prognostic significance of Wang J; Sun K; Chen WM; Wang X; Li LD; Hao Y; Xu N; Jiang H; Xu LP; Wang Y; Zhang XH; Huang XJ; Jiang Q; Qin YZ Leuk Lymphoma; 2023 Mar; 64(3):698-706. PubMed ID: 36642937 [TBL] [Abstract][Full Text] [Related]
35. Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2. van Bodegom D; Zhong J; Kopp N; Dutta C; Kim MS; Bird L; Weigert O; Tyner J; Pandey A; Yoda A; Weinstock DM Blood; 2012 Oct; 120(14):2853-63. PubMed ID: 22915648 [TBL] [Abstract][Full Text] [Related]
36. Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia. Kearney L; Gonzalez De Castro D; Yeung J; Procter J; Horsley SW; Eguchi-Ishimae M; Bateman CM; Anderson K; Chaplin T; Young BD; Harrison CJ; Kempski H; So CW; Ford AM; Greaves M Blood; 2009 Jan; 113(3):646-8. PubMed ID: 18927438 [TBL] [Abstract][Full Text] [Related]
37. Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2-harboring clones as main relapse-driving force in childhood ALL. Morak M; Attarbaschi A; Fischer S; Nassimbeni C; Grausenburger R; Bastelberger S; Krentz S; Cario G; Kasper D; Schmitt K; Russell LJ; Pötschger U; Stanulla M; Eckert C; Mann G; Haas OA; Panzer-Grümayer R Blood; 2012 Dec; 120(26):5134-42. PubMed ID: 23091296 [TBL] [Abstract][Full Text] [Related]
38. HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohort. Page EC; Heatley SL; Eadie LN; McClure BJ; de Bock CE; Omari S; Yeung DT; Hughes TP; Thomas PQ; White DL Oncogene; 2022 Feb; 41(6):797-808. PubMed ID: 34857887 [TBL] [Abstract][Full Text] [Related]
39. Single-cell analysis identifies CRLF2 rearrangements as both early and late events in Down syndrome and non-Down syndrome acute lymphoblastic leukaemia. Potter N; Jones L; Blair H; Strehl S; Harrison CJ; Greaves M; Kearney L; Russell LJ Leukemia; 2019 Apr; 33(4):893-904. PubMed ID: 30487598 [TBL] [Abstract][Full Text] [Related]
40. No prognostic impact of P2RY8-CRLF2 fusion in intermediate cytogenetic risk childhood B-cell acute lymphoblastic leukaemia. Krawczyk J; Haslam K; Lynam P; Kelly J; Storey L; O'Marcaigh A; Langabeer SE; Smith OP Br J Haematol; 2013 Feb; 160(4):555-6. PubMed ID: 23145900 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]